Cryosite Limited (AU:CTE) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Cryosite Limited has reported robust performance and strong cash flow, with plans to expand storage capacity and delve into biological storage and cell & gene therapy services. The company has also appointed Scott Thomas, who brings extensive financial experience, as a new Director. Shareholders are informed that Cryosite aims to pay further dividends in the current year following a successful audit of FY24 financials.
For further insights into AU:CTE stock, check out TipRanks’ Stock Analysis page.